XML 87 R74.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock Incentive Plans - Schedule of Options (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Jun. 30, 2017
Jul. 01, 2016
Mar. 31, 2017
Additional Disclosures      
Total intrinsic value of options exercised $ 29 $ 44  
Stock Options      
Number of Option Shares      
Outstanding beginning of period (in shares) 4,767,396    
Granted (in shares) 1,067    
HPE options converted to DXC options at Merger (in shares) 2,654,872    
CSC Options Converted to RSU's due to Merger (in shares) (1,521,519)    
Exercised (in shares) (711,432)    
Canceled/Forfeited (in shares) (925)    
Expired (in shares) (12,492)    
Outstanding end of period (in shares) 5,176,967   4,767,396
Weighted Average Exercise Price      
Weighted average exercise price - beginning of period (in dollars per share) $ 38.70    
Weighted average exercise price - granted (in dollars per share) 77.00    
Weighted average exercise price - HPE options converted to DXC options at Merger (in dollars per share) 46.56    
Weighted average exercise price - CSC Options converted to RSU's due to merger (in dollars per share) 51.00    
Weighted average exercise price - exercised (in dollars per share) 35.93    
Weighted average exercise price - cancelled/forfeited (in dollars per share) 54.20    
Weighted average exercise price - expired (in dollars per share) 27.59    
Weighted average exercise price - end of period (in dollars per share) $ 39.53   $ 38.70
Additional Disclosures      
Weighted average remaining contractual life (in years) 5 years 11 months 26 days   8 years 4 days
Aggregate intrinsic value $ 193   $ 145
Total intrinsic value of options exercised $ 29    
Vested and Expected to Vest      
Vested and expected to vest in the future as of period end (in shares) 5,166,000    
Exercisable as of period end (in shares) 5,119,465    
Weighted average exercise price vested and expected to vest as of period end (in dollars per share) $ 39.47    
Weighted average exercise price exercisable as of period end (in dollars per share) $ 39.27    
Weighted average remaining contractual life vested and expected to vest in the future as of period end (in years) 5 years 11 months 23 days    
Weighted average remaining contractual life exercisable as of period end (in years) 5 years 11 months 19 days    
Aggregate intrinsic value vested and expected to vest in the future as of period end $ 193    
Aggregate intrinsic value exercisable as of period end $ 192